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COMMENTARY
Vita activa in biotechnology: what we do 
with fungi and what fungi do with us
Martin Weinhold1, Edeltraud Mast‑Gerlach2 and Vera Meyer2* 
Abstract 
Filamentous fungi are fascinating microorganisms. One of the reasons why it is so worthwhile to take a closer look 
at them is their capacity to produce secondary metabolites. Some of these substances have the potential to be of 
great use for mankind, such as it was the case with penicillin and its discovery in 1928. Almost a century later, the 
situation in healthcare could possibly turn back to the state before the development of the first antibiotics. Due to 
an overuse of antibiotics we are facing a surge of multiresistant bacteria that are not inhibited by any of the currently 
known drugs. That was part of the background why a European research project was launched in October 2013, titled 
“Quantitative Biology for Fungal Secondary Metabolite Producers”, or “QuantFung”. Fifteen young scientists embarked 
on a new phase in their career, moving to new work environments within Europe and dedicating their work lives 
intensively to the quest for useful secondary metabolites. After 4 years, the QuantFung project concluded in October 
this year. In this commentary, we aim to convey what it means to work in this field of fungal biotechnology and how 
important it is to improve the efficiency of the research therein. We introduce five out of the fifteen fellows at length 
and let them have their say about the adventure of science, euphoric moments, prospects and doubts. We also raise 
questions about the current state of research in academia, something the QuantFung fellows experienced first‑hand. 
Being a scientist often goes beyond earning money to make one’s living. This is why we also reflect on aspects of the 
meaning of work in our western society, where production for profit’s sake is a main driver. For that we refer to one of 
the most distinguished thinkers of the twentieth century, to Hannah Arendt.
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Background
In 1960, political theorist Hannah Arendt chose “Vita 
activa” as the title for the German edition of her ground-
breaking book “The Human Condition”, a highly complex 
text elaborating on what we actually do when we work 
[1]. “Vita activa” as a philosophical term means to par-
ticipate socially in the complex structures humans cre-
ate to organize themselves. Arendt was highly in favour 
of using the precious good of a given lifetime for the real 
capacities that humans possess. Applied to today’s world 
of work, it would be about capacities that go way beyond 
the daily toil which is necessary to make ends meet. In 
a job-focused society, where income often matters more 
than input, it may sound demanding to ask for a truly 
meaningful work life. Though closely observing recent 
phenomena in the realms of science or industry, it shows 
that we are limiting our perspectives when narrowing 
them down to profit margins. In one example, as it was 
more profitable, the German car industry was investing 
in new software to deceive testing methods for exhaust 
fumes instead of developing new technologies that would 
make the era of internal combustion engines a historic 
one altogether. Turning towards the antibiotics market: 
since the rewards are too low, the number of pharmaceu-
tical companies worldwide went down from 18 in 1990 
to 4 in 2010 [2]. Having the current crisis of antibiotic 
resistance in mind, that is threatening news.
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In October 2017, a European research project con-
cluded that produced a network for 15 young research-
ers working in five different European countries. The 
project started in October 2013 as a 4-year multi-partner 
Innovative Training Network (ITN), as part of the Marie-
Curie Actions in the Seventh Framework Programme 
‘People’ (FP7 people) and was provided with €3.9 million 
(EU Grant number 607332). The focus of the “Quant-
Fung” project was to identify and isolate novel bioactive 
molecules from filamentous fungi. One of the triggers 
for launching this 4-year project was the crisis of antibi-
otic resistance. QuantFung was offering what should be a 
matter of course for such an important field of science: an 
efficient, result-based network of researchers with diverse 
backgrounds and expertise, where communication can 
flow freely and no efforts are doubled. Even though the 
work of these 15 highly committed researchers took into 
account that finally their new knowledge may result in 
new products for the market, it was not its driving force. 
Motivations to join QuantFung were manifold. For all 
participants the chance to gain new knowledge in a fas-
cinating field of research was compelling—“unlocking (a) 
secret door”, as Min Jin Kwon, one of the researchers put 
it [3]. Nonetheless, the idea of producing something that 
society can really benefit from, is of major importance for 
them. Referring back to Hannah Arends idea of a mean-
ingful life, in which humans can unlock their own capaci-
ties and talents, working for the QuantFung project truly 
qualifies for that. In this paper, we take stock of what was 
achieved within the framework of this exciting project, 
and also shed light on life models in (fungal) biotech-
nology. Kindly, a number of QuantFung fellows agreed 
to give a glimpse of what their life was like during the 
last 4 years and what they think can be learnt from their 
experience for future research projects.
The origins of QuantFung
The quest for novel bioactive fungal products goes far 
beyond the problem of the antibiotics crisis, as it includes 
the need for novel drugs for multiple human health 
problems ranging from different cancers to increasing 
neurodegenerative diseases, which are especially promi-
nent in aging societies. The necessity for a multidisci-
plinary training network that can unlock the genomic 
potential of filamentous fungi to produce novel bioac-
tive compounds for human welfare was identified at a 
meeting of the EUROFUNG consortium in November 
2010. EUROFUNG is a virtual centre of excellence and 
includes 35 academic members from 13 European coun-
tries and an associated industrial platform of 9 small, 
medium-sized and large European biotechnological and 
pharmaceutical companies [4]. A cross sector group 
of EUROFUNG active in the field of fungal bioactive 
compounds developed the initial idea for the Quant-
Fung project (Technische Universität Berlin, Univer-
sität Göttingen, Danmarks Tekniske Universitet, DSM). 
QuantFung stands for “Quantitative Biology for Fungal 
Secondary Metabolite Producers”. The concept was fur-
ther developed at the ESF-EMBO symposium “Synthetic 
biology of antibiotic production” in October 2011 [5], 
where additional groups joined (Rijksuniversiteit Gro-
ningen, Leibniz-Institut für Naturstoff-Forschung und 
Infektionsbiologie Jena—Hans-Knöll-Institut, Chalm-
ers tekniska högskola, Debreceni Egyetem, Christian-
Albrechts-Universität zu Kiel, Bioviotica Naturstoffe, 
HiTeXacoat, Planton GmbH, Codexis Laboratories 
Hungary LTD). The intended mission of the ITN was 
to combine internationally renowned research experi-
ence of the EUROFUNG members with new groups and 
their expertise in new technologies for a training network 
exploring the potential of fungi for innovative, bioactive 
products for biotechnology and, at the same time, train-
ing high quality researchers. This intention resulted in a 
first proposal submitted in January 2012 that scored 93.0 
points and was placed on the EU reserve list for fund-
ing. A revised second proposal had been improved by 
addressing the helpful and constructive comments from 
the reviewers of the first evaluation. It also benefited 
from new ideas and refinements that came from a two-
day workshop in October 2012 in Berlin. The submission 
of the subsequent proposal happened in November 2012 
and it was approved in April 2013 with a score of 93.2.
After negotiations involving all academic and indus-
trial partners, the QuantFung project eventually started 
in October 2013 as the first European training platform 
for the production of novel bioactive compounds based 
on fungal systems and synthetic biology [6]. Six months 
were devoted to selecting and recruiting the best fellows 
among the applicants. The eventual start-up meeting for 
all research projects within QuantFung was in March 
2014, which was nearly 3.5 years after the initial idea for 
this EU project was launched.
Combining excellence in training and research
The driving force of QuantFung was the collaboration 
of 8 academic and 5 industrial partners to expedite the 
application of new secondary metabolites in areas such 
as health care, nutrition or agriculture. The main objec-
tives of the consortium were to find novel bioactive mol-
ecules by exploiting the wealth of fungal biodiversity and 
to translate these into useful products. This required the 
(re-)design and engineering of fungal organisms with 
new characteristics, using highly sophisticated synthetic 
biology tools. The educational idea of QuantFung was to 
use this research context to train 11 Ph.D. students and 
4 Post-Docs as new problem-solving, creative European 
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scientists in interdisciplinary and intersectorial biotech-
nological research. The fields varied from modelling 
and network analysis to systems biology (e.g. genomics, 
transcriptomics, proteomics and metabolomics), from 
molecular biology, like fungal genetics and biochemistry, 
to synthetic biology methods. Different work packages 
were designed which focused on discovery of secondary 
metabolite gene clusters, targeted activation of gene clus-
ters, quantification of secondary metabolites in industrial 
hosts, and bioactivity testing to identify their mode of 
action. In order to bridge the gap between academia and 
industry, the industrial partners offered secondments and 
training modules to share their experience with the train-
ees. As these multidisciplinary projects required physical 
and intellectual flexibility, the training program for the 
young fellows included defined work periods in different 
QuantFung laboratories, as well as local and networked 
training events for researchers. The vision of the Quant-
Fung partners was that such an approach would promote 
the development of a new generation of fungal biotech-
nologist with experience in both the academic and the 
industrial work culture, comprising significant transla-
tional and entrepreneurial skills.
What has been achieved?
We decided to address this question on two different lev-
els: On the one hand, we gathered all relevant data and 
information regarding the scientific output of QuantFung 
(e.g. publications, patent applications, poster presenta-
tions, talks at conferences). On the other hand, we were 
using interviews to discuss with members of the consor-
tium the impact QuantFung had on their personal life 
and personal development.
Regarding the evaluation of “hard facts”, we took the 
project’s official end as an effective end date (October 
1st, 2017), even with the knowledge that much of Quant-
Fung’s output cannot yet be taken into account as many 
manuscripts are still in preparation or have just been 
submitted and are currently under review. Therefore, 
the assessment of the endeavor’s effectiveness and out-
come can currently only be a partial one. The overall 
impact will be most likely revealed in 1 or 2 years’ time 
from now. However, the fellows’ accomplishments are 
already very impressive at this early stage: On average, 
each fellow presented his/her work at four (inter)national 
conferences and has been co-author of 1.9 publica-
tions (Table 1). Three of these publications have receive 
particular attention by the research community: (1) the 
establishment of a CRISPR/Cas9 based genome editing 
tool for Penicillium chrysogenum [7], (2) the sequencing 
of nine different Penicillium genomes and the identifica-
tion of 1317 putative secondary metabolite gene clusters 
hidden there [8], (3) the establishment of polycistronic 
gene expression in the cell factory Aspergillus niger as a 
tool for high level production of secondary metabolites 
[9]. As a team, the QuantFung participants jointly organ-
ised one Mini-symposium in 2014 during the annual 
meeting of the German Society of General and Applied 
Microbiology (VAAM) and a session during the highly 
prestigious Conference on the Physiology of Yeast and 
Filamentous Fungi 2016 in Lisbon (PYFF6). The fellows 
used the opportunity to publicize QuantFung to the 
broader audience of biotechnologists and the interested 
public, and collectively co-wrote a commentary piece in 
2015 [3], which resulted in over 2590 downloads during 
the first 2 years after its publication.
On paper, these years of research on filamentous fungi 
were very successful. But what impact did this time have 
on the fellows? We focused on five fellows who provided 
a personal perspective—Min Jin Kwon, Sietske Grijseels, 
Yvonne Nygård, Carsten Pohl and Jens Christian Frøslev 
Nielsen.
The lab away from home
An essential part of the QuantFung ITN project was its 
mobility rule: the fellows had to move to a European 
country where they had not lived during the past 3 years.
For Yvonne, one of the experienced researchers in 
the group, it meant going from Finland to the Neth-
erlands. As she is used to being much further away for 
work assignments (e.g. being for some time in Berke-
ley, USA, as a visiting researcher), the distance between 
her home country and the Netherlands was not a major 
issue. Going for visits back to Finland on an average of 
every 2  months proved to be sufficient, and convenient 
due to non-stop flights from Amsterdam to Helsinki. In 
Yvonne’s perception the main cultural difference was the 
very direct way of Dutch communication, although in the 
lab Dutch people actually were a minority, as she says, 
there it was way more international.
Min Jin, another of the experienced researchers, moved 
from the Netherlands to Berlin to participate in the pro-
ject. It was a familiar place for her, as she had come to 
the German capital before for her master’s degree after 
graduating in South Korea where she was born. Min Jin 
had lived and worked for 5 years straight in the Nether-
lands before QuantFung, therefore she was qualifying for 
the mobility rule.
For Sietske, Carsten and Jens their respective change 
of country kept them culturally fairly close to what they 
knew from home. There were no greater “shocks” to cope 
with than maybe sweeter pastry for Sietske in Denmark 
or for Jens the Swedish consensus culture which was 
quite different from what he was used to in Denmark, 
he explains in the interview. Carsten even said about his 
time in Groningen (Netherlands) that he sometimes felt 
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as if he were just in another German city. “But where I 
really felt like being in Europe was in my lab. There was 
the world at home.” he continues. Counting all the nation-
alities he was working with in the lab actually takes him a 
while, “…that was like a world community, you can surely 
say that”. The international aspect of their research envi-
ronment—and its positive effect—is a shared perception 
among the QuantFung fellows. As Jens mentions about 
his group in Gothenburg: “The main nationality here is 
not Swedish, it’s Chinese. Then you have Indian, quite a 
few Germans and so on. So it’s not only the new Swedish 
culture I learnt about, it’s about all other cultures from 
just anywhere in the world.”
Nonetheless there are challenges when working abroad. 
For instance, figuring out things like tax authorities and 
insurances, which at the same time trains your ability for 
trouble-shooting and asking colleagues who have been 
in the same situation. Then there were the long com-
mutes when you wanted to see family and friends dur-
ing a weekend, using up most of the Friday for travelling. 
Even seemingly close distances within Europe take a toll 
and, as it was also about getting to know the other coun-
try and the people there, travel back home did not occur 
every weekend. For Jens it is one of the reasons why he 
will look for employment in his home country Denmark 
after the QuantFung project. His overall balance with 
the project is absolutely positive but he wants to be back 
where family and friends are. “This kind of work life-style 
(like during an ITN project) does come at a cost” he says. 
Whereas for Sietske going back to the Netherlands would 
now feel a bit like going back to a previous life. After the 
project she will move to Tromsø in Norway instead, for 
living there with somebody she got to know during her 
time in Denmark. “In that way you could say it’s an out-
come of the QuantFung project.” she says with a laugh.
The balance between work and private life
According to Hannah Arendt’s Vita activa (The Human 
Condition), excellence can only be achieved in the pub-
lic realm, as this is the place where we can prove our-
selves as being one of the best, as the place where we 
can stand out because there is comparison and because 
there are people who will notice our achievements. Noth-
ing humans ever do in private can achieve this potential. 
Nonetheless there is the need to have a retreat where we 
are not seen and heard all the time and can recover [1]. 
Table 1 Dissemination of QuantFung results (referring only to publications, patents or presentations within the 4-years 
funding period)
a Note that projects funded by QuantFung for Ph.D. students were for 36 months, whereas post-doctoral fellows were funded for 24 months only
b Note that one publication was a joined publication of all fellows [2]
Co-author 
of peer-reviewed 
 publicationsb
Co-author 
of patent 
applications
Presentations 
at conferences 
(poster or talk)
Future perspectives/remark
Ph.D.a
 1 2 – 8 Successfully defended Ph.D. and continues research career as Post‑Doc in aca‑
demia working on fungi
 2 1 – 8 Ph.D. defence date is envisaged, currently in job interviews
 3 3 2 4 Ph.D. project continues for a 4th year (not funded by QuantFung)
 4 1 – 4 Ph.D. project continues for a 4th year (not funded by QuantFung)
 5 3 – 5 Ph.D. defence date is envisaged, currently in job interviews with academia
 6 2 – 4 Ph.D. project continues for a 4th year (not funded by QuantFung). Already 
obtained a permanent position in a University to work on fungi as a fermenta‑
tion engineer
 7 1 – 2 Ph.D. project continues, which is however not funded by QuantFung
 8 2 – 4 Ph.D. defence date is envisaged, currently in job interviews with industry
 9 4 – 4 Ph.D. project continues (not funded by QuantFung)
 10 1 – – Ph.D. project continues for a 4th year (not funded by QuantFung)
 11 1 – 3 Ph.D. project continues for a 4th year (not funded by QuantFung)
Post‑Doca
 1 1 – 7 Continues career in a private‑public cooperation project at an University working 
on fungi
 2 1 – 3 Continues career in industry
 3 3 2 3 Obtained an Assistant Professorship position
 4 2 – 2 Obtained a permanent position at a research institution
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The QuantFung fellows certainly moved onto a public 
stage when entering the international research commu-
nity during the project. How did they perceive the bal-
ance between their work and the private life?
Sietske (Fig. 1) is looking back very happily with what 
she experienced in Denmark at DTU. There was spare 
time, there were weekends for going out by bike for 
camping tours, which she loves doing. There was also 
a life besides fungi. However, considering future work 
options for herself she tends towards favoring a job in 
industry, despite the fact that she really likes her field of 
research and enjoys being at a university. There is the dif-
ference between her work life during QuantFung, where 
it was totally okay to go home after 5 pm, and then there 
is the other side of academia that she observed: “When 
I see the professors around here at DTU, many of them 
have a family but they work day and night to do the 
research and to apply for grants at the same time.” Espe-
cially for starting a family it could be very hard, she thinks 
“You find a post-doc for one or two years and during that 
period you already have to start writing grant applica-
tions or applying for new positions. … It’s really insecure 
and it’s not sure whether you can stay in the same coun-
try. I think it could be pretty hard to start a family in such 
a position.”
In the project’s beginning, Carsten (Fig. 2) was involved 
in sporting activities outside work, like fencing classes, 
“…but then there was such a dynamics that literally 
sucked me in. One thing led to another and it became 
more and more exciting and then you were checking the 
clock and it was 9 pm and you said to yourself, okay now 
it really is too late for exercise…” For a tangible break he 
needs a change of location, as work issues remain too 
preoccupying for as long as he is close to the lab: “I don’t 
go home in Groningen, close my door and then I don’t 
think about my work anymore, that’s nothing I am capa-
ble of doing. … There was an intense phase during the 
project in which I actually didn’t see the people at home, 
in my flat-sharing community, at all.” Carsten sees it also 
as a way to find a personal limit with work. He says it is 
mainly your own responsibility to decide how much you 
let yourself being consumed personally through work. 
“For me it was voluntary, I really enjoyed that and it was 
not done under pressure and force at all. … But it’s not 
a life model that works as a permanent set-up, certainly 
not.” During longer vacations that brought him away 
from Groningen and the lab, Carsten participated for 
instance twice in a huge bicycle race at the Nürburgring 
(Rad am Ring), something that required proper prepara-
tion and therefore was a real change of subject.
Min Jin (Fig. 3) was living with her family in Berlin and 
therefore combined being a mother of two kids and pur-
suing the project’s ambitious research goals. Within the 
project’s run she took a 10-months maternity leave after 
giving birth to her second child. That is why she says 
without hesitation: “Within the QuantFung project there 
definitely was a good balance for me between private 
Fig. 1 Sietske during a summer weekend trip to Denmark’s largest 
lake Arresø (© by Aaron Andersen)
Fig. 2 Testing the European mobility rule: Carsten racing to the 
interview appointment in Berlin, 2017
Fig. 3 Min Jin entering one of the labs of the TU Berlin, 2015
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and work life.” The favourite thing besides the kingdom 
of fungi for her is playing with her children. But during 
the 6 months in which she had to come to the lab late at 
night for fostering demanding fungal bioreactor cultiva-
tions, she discovered Harry Potter novels as a diverting 
read. “Whenever I was going by public transportation at 
night or in the early morning, I appreciated J.K. Rowling, 
as she made me forget all the tiredness.”
Jens (Fig. 4) had a very intense first year with the group 
in Gothenburg that he had chosen for its combination of 
biology with informatics. It was the year before his girl-
friend moved to Gothenburg. Being by himself in the 
beginning meant that he “could just give the project all 
I had”. The fantastic research environment he found in 
Sweden was exciting and working intensely was therefore 
nothing he had to force himself to. Nonetheless he would 
not like to continue that way in the future: “Even though 
I really liked this intense time, I think it’s just important 
to also have a balance.” And having a balance could mean 
for him something as simple as watching a Champion’s 
League game together with some childhood friends on 
a Wednesday evening. Jens mentions another important 
aspect about the intensity of research work: “the fear of 
failing, as you have this limited time”. The need to publish 
papers, as otherwise you cannot finish the Ph.D., is quite 
a common fear in the back of the mind of Ph.D. students, 
he says. Therefore, the motivation to work hard comes 
from within. “Hopefully it’s more based on your excite-
ment to the work, which is definitely a major driver, but 
also to some degree that you don’t want to fail.”
Even if there are intense work periods, Yvonne (Fig. 5) 
tries to make enough time also for leisure activities and 
meeting friends and family. “I like to think that I work 
very systematically and organized. And all my spare time 
and all my sports activities are also in my calendar.” She 
agrees that sports are the best thing you can do to reju-
venate your energy, a common view among all the inter-
viewed QuantFung fellows. Another favourite pastime for 
Yvonne is being in nature. Asking her about what she did 
in nature in the Netherlands she is just laughing, “That is 
what I missed most in the Netherlands - nature - there 
is not much nature around.” When the subject of the 
blurred border between work and private life comes up 
she quickly replies “There is no border for me.” and con-
tinues: “Of course it’s problematic because it means that 
a lot of weekends I spend working, but I do it because I 
enjoy my work and want to push forward.”
Results and revelations
The outcome of an intense project time usually is a 
diverse one. With respect to QuantFung, for one there 
are measurable, scientific results—as everybody was 
hoping for, even though all the fellows were very much 
aware of the nature of research, i.e. “not all the reason-
able approaches give the results as expected” (Min Jin). 
Then there is also the personal experience gained as a 
researcher when exposed to a new work environment 
and to a new lab with different opportunities to pursue 
the respective project goals. We asked the QuantFung 
fellows about results and revelations, about personal 
changes they noticed, as well as for their perspective on 
fungi after being immersed in this field of research for a 
substantial amount of time.
Sietske describes a measurable outcome that was very 
satisfying for her, and is an example of why and how 
important it is to work together with researchers with 
different expertise. “There was one fungus that produces 
a secondary metabolite, calbistrin, that was found to have 
an anti-cancer activity … We wanted to identify the genes 
encoding the biosynthetic pathway for formation of 
calbistrin. For this we decided to sequence the genome of 
the fungus in which Jens [from the QuantFung group in 
Goteborg] had the leading role. I analysed the structure 
of the compound to predict which enzymatic activities 
would likely be involved in the formation of the second-
ary metabolite and using these predictions I compared 
the genome sequences of three species that all produce 
Fig. 4 Jens during a day trip to the forests of the greater Gothenburg 
area—apparently being successful at picking edible mushrooms, 
2016
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this secondary metabolite, to predict which genes could 
be essential for its formation. Then we had an idea of 
what the gene cluster could be and Carsten [from the 
QuantFung group in Groningen] deleted several of the 
genes with the CRISPR/Cas9 based method that they 
had developed in the QuantFung team in Groningen. 
Fortunately, I saw that deletion of the genes resulted in 
mutant strains that did not produce calbistrin anymore, 
showing the power of combining all these different tech-
niques The knowledge gained in this project could lead 
to the development of metabolic engineering strategies 
for improving calbistrin yields in future cell factories.” 
Sietske is convinced that “doing research changes your 
personality because it is so unpredictable with respect to 
the outcome. There are so many things not working and 
every time you have to tell yourself: Next time it might 
work, okay, there we go again” and that she “can deal 
with that better, after these three years. If things don’t 
work out - it doesn’t matter, we will try to find a differ-
ent way.” Was her perception of the fungal world changed 
throughout the years? Yes. “It is really fascinating how 
they produce these secondary metabolites. … That they 
have these clusters of genes in the genome that all encode 
for enzymes to work together for making these secondary 
metabolites. They are so interesting because they’re all so 
different and we don’t actually know what these second-
ary metabolites are doing in nature, why they are there.”
One of Carsten’s focal points with his QuantFung 
group in Groningen was to develop new synthetic biol-
ogy tools that can be applied to fungi. The group was 
also involved in quantitative biology. That was some-
thing he enjoyed and was a point of pride, as this work 
went beyond descriptive research to generate usable 
facts. Another measurable outcome was the first paper 
he published, which Carsten describes as follows: “We 
established the CRISPR-Cas9 tool in two different ways 
in our fungus. There were papers about this tool work-
ing in fungi before, but we showed a new way where we 
brought the protein into the cell directly, without it being 
expressed by a plasmid. It’s a method that can accelerate 
the process. Additionally, I was able to show that it works 
the same with one of the other QuantFung fellows’ fungi 
[Sietske at DTU]. It was very satisfying to see that it’s not 
just a one-time-wonder I discovered but a method that 
also works reliably with a different fungus. On top, it was 
a method helpful for my own research experiments, as 
it saved a lot of time.” What did this kind of collabora-
tion do with Carsten? “I learnt how much it matters on a 
social level to really find a way of collaboration. I think in 
the beginning I was very naïve, I thought it would work 
automatically and we would get along just because of the 
great and common goal. Then I was surprised to see how 
much the human factor mattered, despite the common 
goal. The individual aspect must not be underestimated 
also when specialists are expected to work together. It’s 
something I intend to improve for myself, to be better at 
team-building.” And: “I still underestimated the diversity 
of fungi. I was specifically working with one organism. 
However, I think one really should review the kingdom of 
fungi as broad as possible to seek after useful molecules.”
Jens’ field is bioinformatics. Therefore, you won’t find 
him in the lab working with fungi, as he sits in front 
of the computer most of his work day. For the Quant-
Fung project he was looking at genome data from vari-
ous fungi. Studying these masses of genetic information 
led to an outcome he was very happy about: “I ended up 
publishing a paper in a journal called Nature Microbiol-
ogy [8]. As I am just a Ph.D. student, I don’t have a huge 
amount of papers yet but I ended up getting something 
quite impactful out of the work we did, out of all these 
work hours spent. That was super nice. That particular 
Fig. 5 Yvonne in the Madurodam themepark in The Hague, picture 
taken by her mother (© Marianne Nygård) during a visit of Yvonne’s 
parents in 2016
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paper may also help me in the future. As for the big-
gest revelation - how conserved everything is in life. 
What I find fascinating about this biology is the similar-
ity between all species. You can take any genome of any 
species - if it’s a human, a bacterium or if it’s a filamen-
tous fungus - and they actually look quite similar from 
my point of view. I think this “conservedness” of biology 
is what I find most fantastic and what I realized during 
my Ph.D. studies. That’s, of course, a little bit “nerdy” but 
I think that holds true and is really fascinating to me.”
In Berlin, Min Jin was looking for global transcription 
factors that regulate secondary metabolite gene expres-
sion in A. niger. From meta-analyses of transcriptomic 
data she predicted regulators in silico and verified their 
role in secondary metabolism by generating mutant 
strains. Even though she is still finalizing the data and 
preparing the paper, this discovery already makes Min 
Jin very happy as an outcome, as she describes: “I was 
afraid that two selected transcription factors maybe not 
be true regulators of secondary metabolism, so I was 
still a bit doubtful about our candidate genes. But when 
I observed colour changes of the cultivation media of 
the mutant strains and also sclerotia formation induced 
by overexpression of one transcription factor, it was the 
moment that I was very happy. A colour change suggests 
that some secondary metabolites were produced and also 
sclerotia formation is not a very common phenomenon 
with Aspergillus niger. Of course, I was very excited to see 
that.” And her perspective on fungi? “At the beginning I 
thought, oh, Aspergillus niger is very interesting, whereas 
now I realize that many filamentous fungi are attractive 
to be studied.”
Yvonne was working for QuantFung in part at the 
University of Groningen and for half the time she had a 
secondment with DSM, where she was employed by one 
of the project’s industrial partners. In her QuantFung 
project they were developing CRISPR gene editing tools 
and also expression systems. The results are partly pub-
lished [7], which is a measurable outcome. New meth-
odologies developed during the QuantFung project 
are now routinely used at the University of Groningen. 
With respect to the importance of comparable data sets 
for research, she says QuantFung could be a good start-
ing point, as the fellows got to know the different proce-
dures and methods in the labs where they were located. 
She carries on: “So you could take that to initiate some 
more standardization but it would need to be more long-
term and also require commitment.” When we asked her 
about her relationship with fungi, she had to laugh: “Well, 
I think it’s a funny way of looking at it. But yes, that hap-
pens, you get to personalize your microorganism that 
you work with; I don’t know whether it’s always all that 
healthy…”.
Better is the enemy of good
“I think it was a very successful project, in general it 
went well.” This is as brief as Yvonne puts her answer 
when asked for an overall balance of QuantFung. That it 
went very well is a common assessment among the fel-
lows who participated in the interviews. All of them see 
the time with QuantFung as an important and substan-
tial period for making progress in their respective fields 
of research. Without a shadow of a doubt it was a true 
gain for their future career path. However, even with a 
successful project there is always space for improve-
ment. Like Carsten, one of the Ph.D. students, puts it “…
that’s nothing that can be preconceived theoretically. … 
Such a project is basically like one of my experiments—
of course you try to make as much risk assessment as 
possible but in the end you have to do it and see what 
it does in real life.” Which is why we asked the fellows, 
now in hindsight, about valued advantages with an ITN, 
about the things that went well in their view and about 
those aspects that were not perfect, so that one can learn 
from their experiences in order to make the next project 
an even better one.
The complementing effect of working on the same 
project, that is on the same fungus, with different tools 
yet the same goal, and communicating about it, is the 
first thing Sietske mentions with respect to advantages 
of this ITN project. During QuantFung she fully real-
ized “… how valuable it is to work with researchers that 
have slightly different backgrounds and work on the same 
project. … You have the biology and the chemistry and 
the bioinformatics and try to combine all of that some-
how. That is something I really enjoyed - to understand 
that all parts are needed to make one story out of that. It 
is also very nice to be able to talk with each other about 
the research - and truly understand each other. When 
you are doing your Ph.D. you get so specific about things 
that even with people who studied the same field, or even 
work in the same lab, it can be quite difficult to talk in 
depth about what you are doing and what your struggles 
are. But when you’re working on the same project and 
writing papers together, then you can discuss in depth 
about ‘where do we want to go’ and ‘what do we need’. … 
And the third thing for me: It is also just fun and nice to 
work together.”
Carsten “can recommend such an ITN to any young 
scientist, I certainly would do that again, absolutely. It 
really broadens the mind when you can go somewhere 
else and don’t stay where you are at home. That’s an 
important aspect. It was a great opportunity for network-
ing, as I don’t know whether I would have been able to 
organize such an access to other colleagues. You may be 
able to meet somebody occasionally during a conference 
but it is not that kind of access that was provided through 
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the meetings we had with QuantFung.” Where would be 
potential for improvement? “It would be good to start 
and extend the networking earlier. It’s just so important 
to be capable of teamwork in science.”
Jens found the overall balance in general a good one. 
“I would recommend everybody joining an ITN. Being 
connected with other research groups within Europe 
has been a real advantage. I really enjoyed that I basi-
cally could come to all the meetings and talk to some of 
the greatest experts in the field. All the issues I had since 
the last meeting, I can take up with some people who are 
the best to talk to about that. This connection for sharing 
knowledge was great.” What was good and helpful within 
QuantFung for your project? “What has been working 
very well for me was that I had a very strong collabora-
tion since the beginning of the project with partners at 
DTU in Denmark [Sietske’s QuantFung group], where 
we’ve been working really closely together. I was doing a 
lot of the computational analysis and they were doing the 
experimental work. With Sietske, you can say both of our 
entire Ph.D. projects were totally intertwined, which has 
been very nice. My research group [in Gothenburg] has 
not been working that much with the filamentous fungi 
but with the bioinformatics techniques. … so I had that 
place in Sweden where I could discuss the methodology 
and so on, while in QuantFung I had another group of 
people where I could share and discuss more biological 
problems. And that kind of interplay has been working 
very well for me.”
For Min Jin the main advantage of the ITN was “to 
meet the different people regularly. The network an ITN 
provides the “human infrastructure” for discussing ideas 
and questions with other researchers. So that you are not 
working isolated by yourself all the time but regularly 
have an exchange - and having this possibility always 
available. … I think it worked very well for me and also 
for my family. I sure would join such a project again.” And 
how about potentials for improvement? “Maybe to be 
better organized from the very beginning. When starting 
as a Ph.D. or a postdoc, it’s always good to have plan, even 
though we don’t know many things in the beginning…”.
For Yvonne, “the network and the collaboration is the 
most valuable aspect for me. It was good for building up 
a network for your future research career. Also, it was 
very valuable to spend time both in the industry and at 
the university. For me the collaboration worked very well 
but for future projects there also should be some flexibil-
ity. Because it doesn’t fit everybody. It was somewhat dif-
ficult for me to move to the other part of the Netherlands 
[for the DSM secondment]. It’s all these practical issues 
that are quite challenging.”
Continuation and prospects
Carsten will be returning to Germany after the Quant-
Fung project. He wants to apply for a job in biotechnol-
ogy in the vicinity of his hometown Potsdam. Besides 
being reunited with his girl-friend, what is he looking 
forward to when he is back home? “My grandmother has 
a garden in Potsdam; as a pastime I actually would like 
to do again some ‘farming’, to watch how things grow 
that I planted.” With respect to his future work, Carsten 
would like to continue to work with fungi. In general, the 
wasteful use of resources in our affluent society makes 
him very concerned, which is why the ecological niche 
for biotechnology is a lot on his mind, like fungal-based 
materials. “I am truly impressed by start-up companies 
such as Ecovative and Mycoworks who turn by-products 
like leftovers from cereal processing into useful, bio-
degradable products such as packaging materials and 
animal-free leather.” Though, he also stresses that “Bio-
technology of the 21st century is going to be very radical 
when fully applied to replace an existing product. When 
I think about the future of synthetic biology and its pos-
sibilities, I am at first very excited about it. But then you 
should also realize that one need to pay price for change: 
it could become a competition to established industries 
and their products—and in the end, this poses a direct 
competition for human labour itself.“.
Sietske is hoping to find a research position in Tromsø 
so that she can continue with her work after the move 
from Denmark to Norway. In Tromsø there is a focus 
on secondary metabolites and enzymes from marine 
organisms, as marine organisms often produce bioac-
tive secondary metabolites and enzymes that are active 
under cold conditions. She would like to join one of the 
research groups working on that and apply the skills 
she learnt from working with fungi. In every case she 
wants to continue with the topic of industrial microbi-
ology. And another thing matters to her: “What I really 
would like to see in the next project is working with 
other researchers and their different perspectives. I like 
approaching research in an interdisciplinary way, as I did 
with QuantFung where I occupied myself with a lot of 
different aspects. …I could see me working in a project 
like that again.”
Min Jin is going to stay at the TU Berlin, where she was 
working during QuantFung. She already started a pri-
vate-public collaboration project working with another 
filamentous fungus. She says: “It is exciting to work with 
different fungi to see some similarity and also differ-
ences.” Min Jin is preparing a grant proposal for a follow-
up project based on the QuantFung results. Obviously, 
her passion for that field of research continues. As for 
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her private life, she thinks that it is comparatively easier 
having a family within the university than in the indus-
try, even though it is never going to be the fixed work day 
from nine to five. Asked about a working hours scheme 
that she would imagine in a perfect world, she says the 
four-days work week would be her favorite: “…for having 
a longer weekend and especially for having one day just 
for myself.”
Jens will return to Denmark, but this comes with the 
decision of what to do after his Ph.D.. In his view, it is 
basically about two options: either following an academic 
track or a career in industry. “I am somewhat inclined to 
go the industrial track where I have a bit more defined 
work hours.” he says. Jens has a lot of positive to say 
about academia and a lot of ideas for new projects to 
do after his Ph.D.. But, “With academia it’s just so hard 
because the thing about working as a professor is that it 
is so competitive; so if you are just going home early and 
you don’t get your papers and you don’t get your grants 
then you don’t have any Ph.D. students—and it’s just this 
vicious circle.” On the other hand he thinks it’s tempting 
to be in an academic environment where you are not as 
predefined in your research as you may encounter in the 
industry where the need to produce a specific product is 
prevailing. With respect to weighing the options he con-
tinues: “I have former colleagues who went straight to 
industry after their Ph.D. and then they thought: ‘that’s 
too strict’. Then they went to academia but realized that’s 
also tough. It can be hard to choose what is exactly good 
for you. Maybe you should end up being your own boss 
by starting some company based on secondary metabo-
lites and filamentous fungi; that could also be a good idea. 
… That’s something I dream about. Let’s see. It could be 
amazing, I think.”
Yvonne already moved from the Netherlands to Swe-
den for a position as assistant professor at the Chalm-
ers University of Technology in Gothenburg (one of 
the QuantFung partner universities). The focus of her 
research has now shifted from the quest for secondary 
metabolites to produce antibiotics to the production of 
fuels and chemicals, where for example the substitution 
of fossil fuels is one of the goals. She says both topics are 
really interesting and that it really matters to her that the 
research she does potentially has an application. In that 
respect her view is a very pragmatic one. “If I would have 
happened to study solar energy then probably I would be 
all into developing solar panels because that’s also impor-
tant. I want to do meaningful work and at the moment 
this is the meaningful work that I do. … I think being a 
scientist is a privilege. I am interested in how things work 
and I daily get to figure out how things work. I think it’s a 
lot of fun.”
The QuantFung legacy
The interdisciplinary research and training programme 
of QuantFung ensured that the fellows became well 
qualified with a broad spectrum of expertise in the field 
of fungal systems and synthetic biology. They are now 
equipped with skills and knowledge to awaken the nat-
ural product reservoir of filamentous fungi, to overpro-
duce compounds of interest and to publish their work in 
peer-reviewed high impact journals. The collaboration of 
different academic and industrial groups led to research-
ers with experience of public and private work cultures 
and an understanding of the wider and commercial 
potential of their work.
For the life sciences and especially biotechnology it is 
essential—like a conditio sine qua non—to work together 
with each other. And this is what the QuantFung fel-
lows have learnt. They never hesitated to ask each other 
because they were peers; there were no obstacles by 
hierarchy, they all communicated on eye level with each 
other. The fellows are thus much more self-confident 
after these years with QuantFung, as well as they are 
more articulate profound in scientific debates. They are 
not intimidated by questions anymore. Instead of evading 
questions they now come up with ideas of how to handle 
an issue, which is an important outcome of the constant 
communication process among the QuantFung fellows. 
They are also way more active asking colleagues dur-
ing presentations, as they now have the courage and the 
experience to do that. These young scientists think along 
with their peers.
Another remarkable progress is the way these young 
scientists handle criticism. Criticism now is perceived as 
something positive among the fellows that underwent the 
QuantFung years. They understand that critical questions 
are nothing negative but see these questions as pieces of 
advice to think about for further improvement of their 
work. The QuantFung fellows thus became more mature 
scientists who grasp critical questions as part of the sci-
entific discourse. Their next step would be to explain and 
picture the research work for the general public, some-
thing which they hopefully will learn during their next 
career steps. All things considered, ITNs such as Quant-
Fung are ideal training networks for the new generation 
of (fungal) scientists. Here they can learn how to share 
scientific know-how and research infrastructures and 
how to turn research results into new technologies and 
products. Furthermore, they experience hands-on the 
importance of the human factor and of cultural exchange 
for unlocking their own capacities and talents. The essen-
tial assets of ITNs are indeed a very good way to advance 
science and enable young scientists to find their paths 
into a truly meaningful work life.
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Everything perfect then?
No, unfortunately not. As indicated by some of the fel-
lows in their interviews, the job of a scientist and the 
career path in academia is not as attractive as it used 
to be. Not because one can make more money in other 
jobs—this is often not as relevant for students and estab-
lished scientists alike, as they are intrinsically motivated 
and gain satisfaction from their daily work. It is because 
the journey into this professional future is such an unse-
cure one. The employment situation in academia is par-
ticularly vulnerable and one has to face the continuous 
challenge to get funding for new projects. This is why 
professors are constantly “swamped and work like mad”, 
to the effect that they are no longer perceived as role 
models for their students. Recently, the head of the 
Department of Experimental Neurology at the Charité 
Berlin, Ulrich Dirnagl, gave a glimpse of what a regular 
Saturday is like for him: Having to read nine project pro-
posals of 50 pages each, plus working on a grant proposal 
himself. He also points out that even under the best of 
circumstances the chance of getting a proposal granted 
is 50%; in the recent past that number is closer to a mere 
10%. If turned down, all the resources that went in the 
application process are basically wasted [10]. When look-
ing at the success rate in ITN applications, that number 
even dropped to 7% (Table 2). A substantial part of sci-
entist’s resources is thus burnt: All the work invested 
in a complex ITN application that can easily take up 
2–3  months, including the creation of a network, the 
communication with potential partners and the actual 
grant writing which comes easily close to 50–60 pages. 
All of this is wasted capacity when the proposal is not 
successful in the end. In fact, it can be considered true 
economic damage, as so many work hours rendered by 
highly qualified experts are simply lost.
How can we make science and research more efficient? 
One suggestion for a new modus operandi to finance 
research in academia would be granting the funds in ret-
rospect. This is a complete change of the current models 
where proposals are evaluated in foresight, proposals that 
are consequently rather promises. How could retrospect 
funding work? Here’s a possible scenario. University 
departments receive a particular budget enabling them 
to do teaching and research. After a period of 3–4 years 
there will be the evaluation of what is achieved with the 
provided funds—e.g. how many (under)graduate stu-
dents defended there thesis (BSc MSc, Ph.D.) and how 
many publications and patents were gained. This assess-
ment then is the base for funding for the next 3–4 years. 
That means the core funding may vary, according to the 
performance and achievements, and scientists would not 
thus need to spend most of their time on grant writing 
with insecure outcome but on doing research. Even years 
with a somewhat lower funding could be used for the 
proper preparation of new projects. Another advantage 
of an assessment in retrospect would be that institutions 
are not getting generous funds only because they have 
by chance somebody in their employ who is brilliant at 
writing grants. Funding then would rather be given to the 
ones demonstrated to bring the best of results.
Another suggestion, particularly for ITNs, would 
be the implementation of so-called two-stage propos-
als. Applicants write at first a project sketch that may 
consist of 2–3 pages only. Here they briefly outline the 
intended application’s concept, mention potential part-
ners and the coordinator’s CV is added, for proving there 
is the experience to realize such a project. In 2017, about 
1400 complete ITN applications were submitted; each of 
them containing 50–60 pages. If these applications were 
reduced to 2–3 pages project sketches and that would 
be taken as base for the reviewer panel to decide who is 
being invited to submit the full application—it clearly 
would make the application/funding process and thus 
science more efficient. Conceivable is a rate of 300 of the 
original 1400 submissions being invited to write full pro-
posals with a chance to get one granted being about 30%. 
In that case it also would give the reviewer panel suffi-
cient time to evaluate full proposals thoroughly. This sys-
tem is in place in Germany, e.g. for calls from the Federal 
Ministry of Education and Research (BMBF).
Table 2 Chances of success for getting an ITN proposal granted
Year of evaluation Budget (Mio €) No. of proposals submitted No. of proposals granted Success rate (%)
2010 243 900 92 10.4
2011 318 863 63 7.4
2012 423 1022 128 12.6
2013 470 1175 150 12.9
2014 405 1161 121 10.5
2015 370 1566 106 6.8
2016 370 1611 109 7.0
2017 370 1437 98 6.8
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Science needs its path! True innovation is often only 
possible at the margins of different scientific disciplines. 
But they must, at first, come together and get to know 
each other; they must comprehend how the other ones 
are working, what their methods are. Out of the 4 years 
with QuantFung, the real time for project work was 
3 years for Ph.D. students and only 2 years for the post-
docs. After these 2–3 years, the QuantFung fellows now 
have a much better idea of what needs to be considered 
when one intends to find and overproduce new second-
ary metabolites from fungi, how important the merge of 
different disciplines is and have achieved their first prom-
ising results. However, QuantFung as a consortium is 
still far away from actually having produced new classes 
of antibiotics, although industrial partners for the full 
pipeline to develop such products were within that net-
work. Clearly, 2–3  years of research are not enough to 
really accomplish such a challenging mission. It is worth 
remembering that it was well over a decade between 
the discovery of penicillin and effective production [11]. 
This is why we propose that the EU consider applications 
for follow-up ITN projects. They should be limited and 
awarded in case of outstanding scientific achievements of 
an ITN consortium.
Conclusions
The QuantFung participants were so immersed in the 
field of fungi, got so intrigued, that actually a number 
of fellows will continue doing research work with these 
organisms. Another QuantFung post-doc, Danielle Trop-
pens, became a passionate blogger on the world of fungi. 
She regularly reports on findings that are curious and fas-
cinating [12]. And as for QuantFung’s coordinator, Vera 
Meyer, another effect came along with her work for the 
QuantFung project (Fig. 6). “Fungi turned out to be not 
only objects of scientific study for me. I also see and use 
them as art objects. It is an opportunity to convey the 
work that we do for the general public, to get them inter-
ested. I don’t see these fields separated, science and art. 
Especially art for me is a means of communication. Since 
I have seen fungi so many times under the microscope, 
they became also aesthetically fascinating creatures for 
me. Fungi are champions for me, and it really intrigues 
me how to use art to give our science, the science around 
fungi, a face.”
ITNs represent one of the best funding instruments 
the EU is offering. They provide an ideal framework 
for international exchange and for building up a vital 
and innovative research environment where knowl-
edge, state-of-the-art technologies and the most mod-
ern equipment can be shared. All of which is what is 
needed to train our next generation of high-calibre sci-
entists, to foster their creativity and to jointly come to 
new scientific breakthroughs. How beneficial it is to have 
such a network was strikingly proven by the success that 
QuantFung had on many levels. There are the measur-
able results and there is the fact that 15 young research-
ers are now exquisitely prepared for a future career in 
biotechnology. The fellows are well qualified with a broad 
portfolio of skills and practical experience of cross sec-
tor working; this will make them strong candidates for 
future employers and underpin their career progression. 
Importantly, taking responsibility for their own develop-
ment has instilled in them at an early stage the impor-
tance of continuous professional development. Such high 
quality and highly competitive candidates are needed in 
both the public and private sectors. Although academia 
may lose great talents, they have excellent chances to take 
up industry posts.
“Antibiotic resistance is one of the biggest threats to 
global health, food security, and development today.” 
[14]. This is the first sentence of the World Health Organ-
ization’s internet fact sheet addressing the crisis of more 
and more frequently failing antibiotic medication. Which 
leaves nobody in doubt about the problem’s dimension. 
There are ambitious researchers in academia who eagerly 
want to contribute to the problem’s solution. But they 
should be given the opportunity to pursue their respec-
tive work lives in a way that leaves them space to breathe, 
instead of keeping them in the uncertainty of perpetual-
temporary contracts and in the frenzy of constant grant 
writing. A “Vita activa” in Hannah Arendt’s view means 
a life spent reaching up to higher goals. Advancing the 
deeper understanding of fascinating organisms like 
Fig. 6 Champi(gn)ons, V. meer, 2017. Parasol mushroom, iron stand, 
shellac, rust (Reproduced with permission from [13])
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filamentous fungi for the sake of human health is cer-
tainly such a goal.
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